0001562180-18-004912.txt : 20181211 0001562180-18-004912.hdr.sgml : 20181211 20181211172551 ACCESSION NUMBER: 0001562180-18-004912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181207 FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kanes Stephen CENTRAL INDEX KEY: 0001612859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 181229553 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-12-07 false 0001597553 Sage Therapeutics, Inc. SAGE 0001612859 Kanes Stephen C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false Chief Medical Officer Stock Option (Right to Buy) 47.70 2018-12-07 4 A false 6600.00 0.00 A 2027-02-06 Common Stock 6600.00 6600.00 D On February 6, 2017, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on December 7, 2018, resulting in the vesting of the option as to 6,600 shares. /s/ Anne Marie Cook as Attorney-in-Fact for Stephen Kanes 2018-12-11